title: Salmeterol and inhaled corticosteroids in patients with persistent asthma.
authors.forename: J R
authors.initials: JR
authors.lastname: Botkin
authors.forename: E
authors.initials: E
authors.lastname: Clayton
authors.forename: R
authors.initials: R
authors.lastname: Nelson
authors.forename: B
authors.initials: B
authors.lastname: Wilfond
authors.forename: M A
authors.initials: MA
authors.lastname: Munger
mesh_terms: D000318:Adrenergic beta-Agonists / Q000627:therapeutic use*; D000420:Albuterol / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D001249:Asthma / Q000188:drug therapy*; D001993:Bronchodilator Agents / Q000627:therapeutic use*; D002648:Child; D005938:Glucocorticoids / Q000627:therapeutic use*; D006801:Humans; D010919:Placebos; D016032:Randomized Controlled Trials as Topic; D000068299:Salmeterol Xinafoate; D013256:Steroids
chemical_list: D000318:Adrenergic beta-Agonists; D000893:Anti-Inflammatory Agents; D001993:Bronchodilator Agents; D005938:Glucocorticoids; D010919:Placebos; D013256:Steroids; D000068299:Salmeterol Xinafoate; D000420:Albuterol